Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Qixiang Rong, Yan Gao, Qichun Cai, Xiaoxiao Wang, Bing Bai, Liqin Ping, Haixia He, Huilan Rao, Yujing Zhang, Zhiming Li, Qingqing Cai, Wenqi Jiang & Huiqiang Huang. (2021) High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL). Expert Review of Anticancer Therapy 21:1, pages 121-127.
Read now
Read now
Bodo E. Lippitz & Robert A. Harris. (2016) Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis . OncoImmunology 5:5.
Read now
Read now
L. M. Pedersen & H. E. Johnsen. (2005) Microalbuminuria is associated with impaired glomerular permselectivity in lymphoma patients. Scandinavian Journal of Clinical and Laboratory Investigation 65:6, pages 477-484.
Read now
Read now
Articles from other publishers (34)
Fabiana Esposito, Maria Rosaria Pascale, Cristiano Tesei, Paola Elda Gigliotti, Alessandra Luciano, Cecilia Angeloni, Massimiliano Marinoni, Federico Meconi, Roberto Secchi, Alberto Patanè, Massimiliano Postorino, Maria Cantonetti & Guglielmo Manenti. (2023) Body Composition in Patients with Follicular Lymphoma: Asso-Ciations between Changes in Radiomic Parameters in Patients Treated with R-CHOP-like and R-B Regimens: LyRa 01F. Cancers 15:4, pages 999.
Crossref
Crossref
Shankargouda Patil, Pradeep Kumar Yadalam, Jagadish Hosmani, Zafar Ali Khan, Zeeshan Heera Ahmed, Vidya Gurram Shankar & Kamran Habib Awan. (2023) Oral immune-mediated disorders with malignant potential/association: An overview. Disease-a-Month 69:1, pages 101349.
Crossref
Crossref
Narendranath Epperla, Walter Hanel & Moshe Talpaz. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
21
.
Alex Reza Gholiha, Peter Hollander, Ingrid Glimelius, Gustaf Hedstrom, Daniel Molin, Henrik HjalgrimKarin E. Smedby, Jamileh Hashemi, Rose-Marie Amini & Gunilla Enblad. (2021) Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma. Blood Advances 5:6, pages 1671-1681.
Crossref
Crossref
Yukiko Kawaguchi, Bungo Saito, Ayaka Nakata, Tomoharu Matsui, Yohei Sasaki, Shotaro Shimada, Maasa Abe, Megumi Watanuki, Yuta Baba, So Murai, Nana Arai, Shun Fujiwara, Nobuyuki Kabasawa, Hiroyuki Tsukamoto, Yui Uto, Kouji Yanagisawa, Norimichi Hattori, Hiroshi Harada & Tsuyoshi Nakamaki. (2020) Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy. International Journal of Hematology 112:3, pages 341-348.
Crossref
Crossref
Ying Li, Chunmei Yang, Liping Mao, Jinghan Wang, Chenying Li & Wenbin Qian. (2017) Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor. Medicine 96:39, pages e8091.
Crossref
Crossref
Estela Maria Silva, Vânia Sammartino Mariano, Paula Roberta Aguiar Pastrez, Miguel Cordoba Pinto, António Gil Castro, Kari Juhani Syrjanen & Adhemar Longatto-Filho. (2017) High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer. PLOS ONE 12:7, pages e0181125.
Crossref
Crossref
Suhendan Ekmekcioglu & Elizabeth A. Grimm. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
17
.
Ting Cheng, Xin Dai, Dan-Li Zhou, Yang Lv & Li-Yun Miao. (2014) Correlation of apolipoprotein A-I kinetics with survival and response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer. Medical Oncology 32:1.
Crossref
Crossref
Darren R. Brenner, Dominique Scherer, Kenneth Muir, Joellen Schildkraut, Paolo Boffetta, Margaret R. Spitz, Loic Le Marchand, Andrew T. Chan, Ellen L. Goode, Cornelia M. Ulrich & Rayjean J. Hung. (2014) A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research. Cancer Epidemiology, Biomarkers & Prevention 23:9, pages 1729-1751.
Crossref
Crossref
Yundeok KimSoo Jeong KimDohyu HwangJieun JangShin-Young HyunYu Ri KimJin Seok KimYoo Hong MinJune-Won Cheong. (2014) The Modified Glasgow Prognostic Scores as a Predictor in Diffuse Large B Cell Lymphoma Treated with R-CHOP Regimen. Yonsei Medical Journal 55:6, pages 1568.
Crossref
Crossref
Razelle Kurzrock, Peter M. Voorhees, Corey Casper, Richard R. Furman, Luis Fayad, Sagar Lonial, Hossein Borghaei, Sundar Jagannath, Lubomir Sokol, Saad Z. Usmani, Helgi van de Velde, Xiang Qin, Thomas A. Puchalski, Brett Hall, Manjula Reddy, Ming Qi & Frits van Rhee. (2013) A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease. Clinical Cancer Research 19:13, pages 3659-3670.
Crossref
Crossref
Chin Hao Chang, Chin Fu Hsiao, Yu Min Yeh, Gee Chen Chang, Ying Huang Tsai, Yuh Min Chen, Ming Shyan Huang, Hui Ling Chen, Yao Jen Li, Pan Chyr Yang, Chien Jen Chen, Chao A. Hsiung & Wu Chou Su. (2012) Circulating interleukin‐6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy. International Journal of Cancer 132:9, pages 1977-1985.
Crossref
Crossref
Kelly Vallance, Jie Yang, Jiang Li, Valerie McLaughlin Crabtree, Pamela S. Hinds & Belinda N. Mandrell. (2011) Disturbed Sleep in Pediatric Patients With Leukemia: The Potential Role of <i>Interleukin-6</i> (-174GC) and <i>Tumor Necrosis Factor</i> (-308GA) Polymorphism. Oncology Nursing Forum 38:5, pages E365-E372.
Crossref
Crossref
Toni Valković, Antica Duletić-Načinović, Sanja Štifter, Milena Hasan, Ita Hadžisejdić, David Zombori, Blaženka Grahovac & Nives Jonjić. (2010) Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma. Clinical and Experimental Medicine 10:4, pages 229-235.
Crossref
Crossref
Chun-Ru Hsu, Tsong-Ming Lu, Lengsu William Chin & Chi-Chiang Yang. (2010) Possible DNA Viral Factors of Human Breast Cancer. Cancers 2:2, pages 498-512.
Crossref
Crossref
Sana Intidhar Labidi, Christine Ménétrier-Caux, Sylvie Chabaud, Catherine Chassagne, Catherine Sebban, Thérèse Gargi, Pierre Biron, Jean-Yves Blay & Hervé Ghesquières. (2009) Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival. Annals of Hematology 89:1, pages 25-33.
Crossref
Crossref
Otoniel Martínez-Maza, Alan Duane Moreno & Wendy Cozen. 2010. Cancer and IgE. Cancer and IgE
79
136
.
A. NAČINOVIĆ-DULETIĆ, S. ŠTIFTER, Š. DVORNIK, Ž. ŠKUNCA & NIVES JONJIĆ. (2008) Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma. International Journal of Laboratory Hematology 30:3, pages 230-239.
Crossref
Crossref
David S. Hong, Laura S. Angelo & Razelle Kurzrock. (2007) Interleukin‐6 and its receptor in cancer. Cancer 110:9, pages 1911-1928.
Crossref
Crossref
Mark P. Purdue, Qing Lan, Anne Kricker, Andrew E. Grulich, Claire M. Vajdic, Jennifer Turner, Denise Whitby, Stephen Chanock, Nathaniel Rothman & Bruce K. Armstrong. (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 28:3, pages 704-712.
Crossref
Crossref
Lars Møller Pedersen, Tobias Wirenfeldt Klausen, Ulla Høy Davidsen & Hans Erik Johnsen. (2005) Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin’s lymphoma. Annals of Hematology 84:8, pages 510-516.
Crossref
Crossref
Lynda Song, Andrei Zlobin, Pushpankur Ghoshal, Qing Zhang, Christiane Houde, Sanne Weijzen, Qun Jiang, Elizabeth Nacheva, Danny Yagan, Eric Davis, Sylvie Galiegue-Zouitina, Daniel Catovsky, Thomas Grogan, Richard I. Fisher, Lucio Miele & Lionel J. Coignet. (2005)
Alteration of
SMRT
Tumor Suppressor Function in Transformed Non-Hodgkin Lymphomas
. Cancer Research 65:11, pages 4554-4561.
Crossref
Crossref
Georgios V. Georgakis & Anas Younes. 2005. Cytokines and Cancer. Cytokines and Cancer
69
102
.
Behnam Ebrahimi, Susan L. Tucker, Donghui Li, James L. Abbruzzese & Razelle Kurzrock. (2004) Cytokines in pancreatic carcinoma. Cancer 101:12, pages 2727-2736.
Crossref
Crossref
M. El Far, M. Fouda, R. Yahya & H. El Baz. (2004) Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin’s lymphomaNiveles séricos de IL-10 y de IL-6 como factores de pronóstico en el linfoma no Hodgkin. Journal of Physiology and Biochemistry 60:4, pages 253-258.
Crossref
Crossref
Roberto Salgado, Sara Junius, Ina Benoy, Peter Van Dam, Peter Vermeulen, Eric Van Marck, Philippe Huget & Luc Y. Dirix. (2002) Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer. International Journal of Cancer 103:5, pages 642-646.
Crossref
Crossref
Sasha Bernatsky, Ann Clarke & Rosalind Ramsey-Goldman. (2002) Malignancy and systemic lupus erythematosus. Current Rheumatology Reports 4:4, pages 351-358.
Crossref
Crossref
EM Tegg, AE Griffiths, RM Lowenthal, DM Tuck, R Harrup, KA Marsden, DML Jupe, S Ragg & JP Matthews. (2001) Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation. Bone Marrow Transplantation 28:10, pages 929-933.
Crossref
Crossref
N Niitsu, M Okamoto, J Okabe-Kado, T Takagi, T Yoshida, S Aoki, Y Honma & M Hirano. (2001) Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma. Leukemia 15:5, pages 832-839.
Crossref
Crossref
Luis FayadMichael J. KeatingJames M. ReubenSusan O'BrienBang-Ning LeeSusan LernerRazelle Kurzrock. (2001) Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 97:1, pages 256-263.
Crossref
Crossref
Claudio Belluco, Donato Nitti, Marylin Frantz, Paola Toppan, Daniela Basso, Mario Plebani, Mario Lise & J. Milburn Jessup. (2000) Interleukin-6 Blood Level Is Associated With Circulating Carcinoembryonic Antigen and Prognosis in Patients With Colorectal Cancer. Annals of Surgical Oncology 7:2, pages 133-138.
Crossref
Crossref
Hossein C. Nousari, Arash Kimyai-Asadi & Grant J. Anhalt. (1999) Elevated Serum Levels of Interleukin-6 in Paraneoplastic Pemphigus. Journal of Investigative Dermatology 112:3, pages 396-398.
Crossref
Crossref
J Milburn Jessup. (1998) Tumor markers – prognostic and therapeutic implications for colorectal carcinoma. Surgical Oncology 7:3-4, pages 139-151.
Crossref
Crossref